Tus kws kho mob
P33-21 Change to Medical Review Process for Outpatient Therapies Services
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2021
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 2271 - 2280 ntawm 3288
Tus kws kho mob
QP45-21 Medical Drug Update for Botulinum Toxins (Myobloc, Botox, Dysport, Xeomin) - Commercial Products
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 26, 2021
Tus kws kho mob
QP46-21 Incorrect ID Cards Issued for Minnesota Health Care Programs Members
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 26, 2021
Tus kws kho mob
QP43-21 MHCP Pharmacy Benefit Exclusion for Jemperli and Zynlonta™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 26, 2021
Tus kws kho mob
QP44-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Zeposia® (ozanimod)
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 26, 2021
Tus kws kho mob
2021 June Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2021
Tus kws kho mob
QP41-21 Commercial and MHCP Pharmacy Benefit Exclusion for Qutenza®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 12, 2021
Tus kws kho mob
QP40-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 1, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 12, 2021
Tus kws kho mob
QP42-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Agents
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 12, 2021
Tus kws kho mob
P31-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 03, 2021